Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

NCT00637923 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Nitazoxanide
DRUG: Placebo
BIOLOGICAL: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Romark Laboratories L.C.